Details of Bacterial Vaccine
This bacterial vaccine card gives comprehensive information about each vaccine.
Detailed Information | |
---|---|
ID | 1235 |
Name of the vaccine | VLA84 |
Microbe | Bacteria |
Disease name | Clostridium Difficile Infection |
Name of bacteria | Clostridium difficile |
Type of vaccine | Recombinant |
Nucleic acid content | Linear DNA |
Age | 50 years and older |
Description of the vaccine | Recombinant fusion protein consisting of truncated Clostridium difficile toxin A and toxin B. |
Name of the manufacturer | Valneva Austria GmbH |
Name of the manufacturing country | Germany, United States |
Year of manufacture | 2015 |
Clinical Phase status | Clinical - Phase 2 |
Bacterial strain | Gram-positive bacillus. |
Efficacy | NA |
Vaccine formulation | Suspension for injection |
Dosage | Different combinations of doses. |
Mechanism of action | NA |
Route of administration | Intramuscular |
Indications | NA |
Export | NA |
Approval | NA |
Adjuvant | With or without Alum |
Repurposing | NA |
Side effects of vaccine | NA |
Post vaccination | NA |
Dose type | Combination doses |
Interspecies transfer | NA |
PubMed identifier | NA |
Clinical trial number | NCT02316470 |
Reference | NA |
Other name | NA |
Additional Links | NA |